GlassScriptPhysician profile
Kelsey D Patel
NPI 1396194916
$9,367.59
in general payments reported to CMS, 2019-2025
19 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $487 · 2021: $1,065 · 2022: $2,444 · 2023: $3,928 · 2024: $826 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,758 · Travel and Lodging: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,757.89 |
| Travel and Lodging | $1,314.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,758.77 | 2021-2025 | Cardiomems, Gallant, Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $892.26 | 2021-2025 | Uptravi, Opsumit |
| Amgen INC. | $636.57 | 2022-2023 | Repatha |
| Impulse Dynamics (USA) INC. | $606.56 | 2022-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $592.05 | 2019-2025 | Lifevest |
| Abiomed | $533.89 | 2021-2023 | Impella |
| Astrazeneca Pharmaceuticals LP | $426.51 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.32 | 2019-2023 | Jardiance |
| Medtronic, INC. | $161.30 | 2022-2024 | Cobalt Dr Mri Surescan, Mycarelink, Capsurefix Novus Mri Surescan |
| Edwards Lifesciences Corporation | $158.54 | 2023-2025 | Sapien 3 Ultra Resilia, The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Cardiovascular Systems INC. | $80.03 | 2020 | |
| Merck Sharp & Dohme LLC | $72.95 | 2022-2024 | Winrevair |
| E.R. Squibb & Sons, L.L.C. | $46.44 | 2021-2022 | |
| Terumo Medical Corporation | $42.08 | 2020 | |
| Amarin Pharma, INC. | $37.69 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $30.31 | 2022 | |
| Alnylam Pharmaceuticals INC. | $28.54 | 2022 | |
| Teleflex LLC | $17.23 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.